Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis

The Original Article was published on 22 July 2015

Nature Communications 6: Article number:7736 (2015); Published: 22 July 2015; Updated: 26 October 2015

The affiliation details for Jan Pencik are incorrect in this Article. The correct affiliation details for this author are given below:

Ludwig Boltzmann Institute for Cancer Research, Waehringerstrasse 13A, 1090 Vienna, Austria.

Clinical Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria.


Additional information

The online version of the original article can be found at 10.1038/ncomms8736

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pencik, J., Schlederer, M., Gruber, W. et al. Erratum: STAT3 regulated ARF expression suppresses prostate cancer metastasis. Nat Commun 6, 8802 (2015).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing